| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
RBC Capital analyst Ben Hendrix maintains Acadia Healthcare Co (NASDAQ:ACHC) with a Outperform and lowers the price target f...
Guggenheim analyst Jason Cassorla maintains Acadia Healthcare Co (NASDAQ:ACHC) with a Buy and lowers the price target from $...
UBS analyst Andrew Mok maintains Acadia Healthcare Co (NASDAQ:ACHC) with a Buy and lowers the price target from $31 to $28.
Cantor Fitzgerald analyst Sarah James maintains Acadia Healthcare Co (NASDAQ:ACHC) with a Neutral and lowers the price targe...
Barclays analyst Andrew Mok maintains Acadia Healthcare Co (NASDAQ:ACHC) with a Equal-Weight and lowers the price target fro...
On October 30, 2025, Dr. Nasser Khan notified the Company of his resignation as Chief Operating Officer ("COO") of the ...
Acadia Healthcare Co (NASDAQ:ACHC) lowers FY2025 Adj EPS guidance from $2.45-$2.65 to $2.35-$2.45 vs $2.48 analyst estimate. Lo...